Drug Trial Radar · NCT06997159
A Clinical Trial to Investigate Efficacy, Safety and Pharmacokinetics (PK) of Two LXE408 Oral Regimens and Oral Miltefosine as Active Control in Participants Aged ≥ 18 Years Old With Localized Cutaneous Leishmaniasis in the Region of the Americas (AMR).
Last checked: Nov 19, 2026Latest source record: May 5, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
250
Planned (sponsor's estimate)
Start
Jun 15, 2026
Primary completion
Apr 5, 2028
Study completion Apr 5, 2028
Sponsor
- Lead sponsor
- Drugs for Neglected DiseasesAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Novartis Pharmaceuticals
- First posted
- May 30, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this clinical trial is to measure efficacy, safety and pharmacokinetics (PK) of two LXE408 oral regimens and oral miltefosine tablets as active control in localized cutaneous leishmaniasis in the region of the Americas (AMR), and assess its suitability for use in monotherapy for the treatment of patients with cutaneous leishmaniasis (CL).
Conditions
- Localized Cutaneous Leishmaniasis
Interventions
LXE408Drug
LXE408 film-coated tablets.
Miltefosine 50 MG Oral Capsule [Impavido]Drug
Each capsule contains 50 mg miltefosine in an opaque, red, hard gelatin capsule. Capsules are supplied in packs of 56 capsules sealed in 8 aluminum blister stripes, each containing 7 capsules.
Placebo to LXE408Drug
Film-coated tablets.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants who achieved Cure at Day 180Time frame: 180 days
Locations
5 sites in 2 countries. Site status is shown where the registry gives one.
Foundation of Tropical Medicine Dr. Heitor Vieira Dourado
Manaus, Amazonas, Brazil
Federal University of Maranhão
São Luís, Maranhão, Brazil
Julio Muller University Hospital/ Federal University of Mato Grosso
Cuiabá, Mato Grosso, Brazil
René Rachou Institute /Oswaldo Cruz Foundation- FIOCRUZ MINAS
Belo Horizonte, Minas Gerais, Brazil
Instituto Conmemorativo Gorgas de Estudios de la Salud
Panama City, Panama
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.